THOR therapeutics is a KAIST spin-off biopharmaceutical company, located in Seongnam (Korea), and founded in 2022.
READ MORE
Tech and Hearts Orbiting Recovery
THOR
THOR : Tech and hearts orbiting recovery
THOR Therapeutics is a pioneering biopharmaceutical company blocking the GDF15-GFRAL axis at its receptor source to deliver targeted therapies for cancer cachexia and immuno-oncology.
ABOUT US
OUR MISSION
THOR Therapeutics develops therapies that address cancer as a systemic disease - not only the tumor, but the metabolic and immunological collapse it drives.
READ MORE
LOCATION
ADDRESS : (13453) A203, Startup Square, 40, Geumto-ro 80beon-gil, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
TEL : 82-42-350-0436
E-mail : thor@thortherapeutics.com
OUR SCIENCE
Pioneering targeted therapies against cancer cachexia and immuno-oncology.
TARGETS AND PIPELINE
Receptor-level GFRAL inhibition and novel mechanisms for oncologic, cachectic and systemic therapeutics
